Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

<h4>Background</h4>Degludec is an ultralong-acting, once-daily basal insulin that is approved for use in adults, adolescents, and children with diabetes. Previous open-label studies have shown lower day-to-day variability in the glucose-lowering effect and lower rates of hypoglycemia among patients ... View More